GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,729,000 | +2.7% | 201,624 | -51.8% | 0.00% | 0.0% |
| Q2 2022 | $13,374,000 | +9.6% | 418,606 | +18.9% | 0.00% | +33.3% |
| Q1 2022 | $12,197,000 | +437.1% | 352,086 | +353.8% | 0.00% | +200.0% |
| Q4 2021 | $2,271,000 | +62.0% | 77,589 | +41.1% | 0.00% | – |
| Q3 2021 | $1,402,000 | +11.4% | 54,993 | +53.1% | 0.00% | – |
| Q2 2021 | $1,259,000 | -11.5% | 35,917 | +2.9% | 0.00% | – |
| Q1 2021 | $1,423,000 | -80.5% | 34,900 | -79.3% | 0.00% | -100.0% |
| Q4 2020 | $7,299,000 | +34.5% | 168,531 | +71.2% | 0.00% | 0.0% |
| Q3 2020 | $5,428,000 | +27.1% | 98,462 | +45.5% | 0.00% | 0.0% |
| Q2 2020 | $4,272,000 | +40.3% | 67,674 | +13.6% | 0.00% | +100.0% |
| Q1 2020 | $3,044,000 | -12.4% | 59,586 | +36.3% | 0.00% | 0.0% |
| Q4 2019 | $3,474,000 | +253.8% | 43,709 | +115.9% | 0.00% | – |
| Q3 2019 | $982,000 | +1593.1% | 20,241 | +1728.5% | 0.00% | – |
| Q2 2019 | $58,000 | -55.7% | 1,107 | -55.5% | 0.00% | – |
| Q1 2019 | $131,000 | +24.8% | 2,488 | -3.2% | 0.00% | – |
| Q4 2018 | $105,000 | +8.2% | 2,571 | +0.4% | 0.00% | – |
| Q3 2018 | $97,000 | -98.7% | 2,560 | -98.4% | 0.00% | -100.0% |
| Q2 2018 | $7,224,000 | -14.6% | 159,826 | -8.7% | 0.00% | -25.0% |
| Q1 2018 | $8,458,000 | +262.1% | 175,113 | +195.0% | 0.00% | +300.0% |
| Q4 2017 | $2,336,000 | +1710.9% | 59,367 | +1333.6% | 0.00% | – |
| Q3 2017 | $129,000 | +658.8% | 4,141 | +552.1% | 0.00% | – |
| Q2 2017 | $17,000 | +6.2% | 635 | +45.3% | 0.00% | – |
| Q1 2017 | $16,000 | -23.8% | 437 | -69.0% | 0.00% | – |
| Q4 2016 | $21,000 | +40.0% | 1,408 | +111.7% | 0.00% | – |
| Q3 2016 | $15,000 | +36.4% | 665 | 0.0% | 0.00% | – |
| Q2 2016 | $11,000 | 0.0% | 665 | 0.0% | 0.00% | – |
| Q1 2016 | $11,000 | -35.3% | 665 | +66.2% | 0.00% | – |
| Q3 2015 | $17,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |